222 related articles for article (PubMed ID: 8905341)
61. Persistent binding and functional antagonism by xanomeline at the muscarinic M5 receptor.
Grant MK; El-Fakahany EE
J Pharmacol Exp Ther; 2005 Oct; 315(1):313-9. PubMed ID: 16002459
[TBL] [Abstract][Full Text] [Related]
62. Evidence for facilitatory and inhibitory muscarinic receptors on postganglionic sympathetic nerves in mouse isolated atria.
Cost M; Majewski H
Br J Pharmacol; 1991 Apr; 102(4):855-60. PubMed ID: 1713109
[TBL] [Abstract][Full Text] [Related]
63. Effects of agonist efficacy on desensitization of phosphoinositide hydrolysis mediated by m1 and m3 muscarinic receptors expressed in Chinese hamster ovary cells.
Hu J; Wang SZ; el-Fakahany EE
J Pharmacol Exp Ther; 1991 Jun; 257(3):938-45. PubMed ID: 1710663
[TBL] [Abstract][Full Text] [Related]
64. Cloning and expression of a G protein-linked acetylcholine receptor from Caenorhabditis elegans.
Lee YS; Park YS; Chang DJ; Hwang JM; Min CK; Kaang BK; Cho NJ
J Neurochem; 1999 Jan; 72(1):58-65. PubMed ID: 9886054
[TBL] [Abstract][Full Text] [Related]
65. Muscarinic cholinoceptor activation modulates DNA synthesis and CD40 expression in fibroblast cells.
Casanova M; Furlán C; Sterin-Borda L; Borda ES
Auton Autacoid Pharmacol; 2006 Jul; 26(3):293-301. PubMed ID: 16879495
[TBL] [Abstract][Full Text] [Related]
66. In primary neuronal cultures muscarinic m1 and m3 receptor mRNA levels are regulated by agonists, partial agonists and antagonists.
Brusa R; Gamalero SR; Genazzani E; Eva C
Eur J Pharmacol; 1995 Mar; 289(1):9-16. PubMed ID: 7781716
[TBL] [Abstract][Full Text] [Related]
67. Binding and functional profiles of the selective M1 muscarinic receptor antagonists trihexyphenidyl and dicyclomine.
Giachetti A; Giraldo E; Ladinsky H; Montagna E
Br J Pharmacol; 1986 Sep; 89(1):83-90. PubMed ID: 2432979
[TBL] [Abstract][Full Text] [Related]
68. Muscarinic activity of McN-A-343 and its value in muscarinic receptor classification.
Eglen RM; Kenny BA; Michel AD; Whiting RL
Br J Pharmacol; 1987 Apr; 90(4):693-700. PubMed ID: 2437988
[TBL] [Abstract][Full Text] [Related]
69. Distinct functional muscarinic receptors in guinea-pig gallbladder, ileum and atria.
Karaalp A; Akici A; Akbulut H; Ulusoy NB; Oktay S
Pharmacol Res; 1999 May; 39(5):389-95. PubMed ID: 10328997
[TBL] [Abstract][Full Text] [Related]
70. Pharmacological characterization of muscarinic receptor subtypes mediating vasoconstriction of human umbilical vein.
Pujol Lereis VA; Hita FJ; Gobbi MD; Verdi MG; Rodriguez MC; Rothlin RP
Br J Pharmacol; 2006 Mar; 147(5):516-23. PubMed ID: 16444291
[TBL] [Abstract][Full Text] [Related]
71. Rat hippocampal muscarinic autoreceptors are similar to the M2 (cardiac) subtype: comparison with hippocampal M1, atrial M2 and ileal M3 receptors.
Richards MH
Br J Pharmacol; 1990 Apr; 99(4):753-61. PubMed ID: 1694463
[TBL] [Abstract][Full Text] [Related]
72. Prejunctional muscarinic (M1)-receptor interactions on guinea-pig ileum: lack of effect of cisapride.
Schuurkes JA; Van Bergen PJ; Van Nueten JM
Br J Pharmacol; 1988 May; 94(1):228-34. PubMed ID: 2456809
[TBL] [Abstract][Full Text] [Related]
73. Roles of threonine 192 and asparagine 382 in agonist and antagonist interactions with M1 muscarinic receptors.
Huang XP; Nagy PI; Williams FE; Peseckis SM; Messer WS
Br J Pharmacol; 1999 Feb; 126(3):735-45. PubMed ID: 10188986
[TBL] [Abstract][Full Text] [Related]
74. Functional characterization and potential applications for enhanced green fluorescent protein- and epitope-fused human M1 muscarinic receptors.
Weill C; Galzi JL; Chasserot-Golaz S; Goeldner M; Ilien B
J Neurochem; 1999 Aug; 73(2):791-801. PubMed ID: 10428077
[TBL] [Abstract][Full Text] [Related]
75. Pseudo-noncompetitive antagonism of M1, M3, and M5 muscarinic receptor-mediated Ca2+ mobilization by muscarinic antagonists.
Kukkonen JP; Näsman J; Rinken A; Dementjev A; Akerman KE
Biochem Biophys Res Commun; 1998 Feb; 243(1):41-6. PubMed ID: 9473476
[TBL] [Abstract][Full Text] [Related]
76. Enhancement of maximal activation of neuronal nitric oxide synthase at muscarinic M1 receptors following prolonged agonist treatment.
Cuadra AE; El-Fakahany EE
Eur J Pharmacol; 1997 Sep; 334(1):107-10. PubMed ID: 9346336
[TBL] [Abstract][Full Text] [Related]
77. Activations of muscarinic M
Koga K; Matsuzaki Y; Honda K; Eto F; Furukawa T; Migita K; Irie K; Mishima K; Ueno S
Mol Pain; 2017 Jan; 13():1744806917692330. PubMed ID: 28326934
[TBL] [Abstract][Full Text] [Related]
78. Pharmacologic comparison of selected agonists for the M1 muscarinic receptor in transfected murine fibroblast cells (B82).
Mei L; Lai J; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1991 Feb; 256(2):689-94. PubMed ID: 1704434
[TBL] [Abstract][Full Text] [Related]
79. Functional effects of the muscarinic receptor agonist, xanomeline, at 5-HT1 and 5-HT2 receptors.
Watson J; Brough S; Coldwell MC; Gager T; Ho M; Hunter AJ; Jerman J; Middlemiss DN; Riley GJ; Brown AM
Br J Pharmacol; 1998 Dec; 125(7):1413-20. PubMed ID: 9884068
[TBL] [Abstract][Full Text] [Related]
80. Determination of [35S]guanosine-5'-O-(3-thio)triphosphate binding mediated by cholinergic muscarinic receptors in membranes from Chinese hamster ovary cells and rat striatum using an anti-G protein scintillation proximity assay.
DeLapp NW; McKinzie JH; Sawyer BD; Vandergriff A; Falcone J; McClure D; Felder CC
J Pharmacol Exp Ther; 1999 May; 289(2):946-55. PubMed ID: 10215674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
